Invesco
TRHC

Invesco’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Invesco’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-355,340
Closed -$2.93M – 3927
2023
Q2 		$2.93M Buy
+355,340
New +$2.13M ﹤0.01% 2501
2023
Q1 		– Sell
-47,202
Closed -$234K – 4040
2022
Q4 		$234K Sell
47,202
-240
-0.5% -$989 ﹤0.01% 3625
2022
Q3 		$228K Sell
47,442
-2,652
-5% -$11.4K ﹤0.01% 3638
2022
Q2 		$129K Buy
50,094
+382
+0.8% +$1.43K ﹤0.01% 3840
2022
Q1 		$286K Sell
49,712
-98,703
-67% -$886K ﹤0.01% 3655
2021
Q4 		$2.23M Buy
148,415
+11,621
+8% +$212K ﹤0.01% 2755
2021
Q3 		$3.59M Sell
136,794
-560
-0.4% -$20.6K ﹤0.01% 2559
2021
Q2 		$6.87M Buy
137,354
+2,192
+2% +$98.1K ﹤0.01% 2286
2021
Q1 		$6.22M Buy
135,162
+7,254
+6% +$346K ﹤0.01% 2262
2020
Q4 		$5.48M Buy
127,908
+18,420
+17% +$699K ﹤0.01% 2136
2020
Q3 		$4.46M Buy
109,488
+60
+0.1% +$2.99K ﹤0.01% 2064
2020
Q2 		$5.99M Buy
109,428
+611
+0.6% +$35K ﹤0.01% 1893
2020
Q1 		$5.69M Sell
108,817
-5,408
-5% -$293K ﹤0.01% 1803
2019
Q4 		$5.56M Sell
114,225
-27,794
-20% -$1.3M ﹤0.01% 2105
2019
Q3 		$7.8M Sell
142,019
-20,901
-13% -$1.2M ﹤0.01% 1861
2019
Q2 		$8.13M Sell
162,920
-52,813
-24% -$2.63M ﹤0.01% 1880
2019
Q1 		$12.2M Sell
215,733
-97,451
-31% -$5.81M ﹤0.01% 1477
2018
Q4 		$20M Sell
313,184
-69,219
-18% -$4.9M 0.01% 1139
2018
Q3 		$31M Buy
382,403
+139,466
+57% +$10.2M 0.01% 1037
2018
Q2 		$15.5M Buy
242,937
+200,287
+470% +$9.82M 0.01% 1391
2018
Q1 		$1.66M Sell
42,650
-39,260
-48% -$1.38M ﹤0.01% 2720
2017
Q4 		$2.3M Buy
81,910
+70,095
+593% +$2.05M ﹤0.01% 2491
2017
Q3 		$316K Buy
11,815
+391
+3% +$7.46K ﹤0.01% 3439
2017
Q2 		$172K Buy
+11,424
New +$154K ﹤0.01% 3607

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BSCM
Berry Street Capital Management London, United Kingdom $340M AUM 65.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Invesco's TRHC Position: Q3 2023 in Review

Invesco sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2023, closing a stake of 355,340 shares — an estimated $2.93M sold.

Invesco first reported a position in TRHC in Q2 2017 and held it in 24 quarters. The position peaked at $31M in Q3 2018. 84 funds tracked by Wall St. Rank hold TRHC as of Q3 2023.

  • Invesco reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Invesco sold 355,340 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2023, an estimated $2.93M.
  • Invesco first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2017 and held it in 24 quarters.
  • Invesco's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $31M in Q3 2018.
  • 84 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2023.

Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.